Overview
Vibeke Horstmann practices practicing medicine in Lund, Sweden.
Their clinical expertise encompasses Delirium Tremens, Milroy Disease, Lymphedema, and Neurotoxicity Syndromes.
They are actively involved in clinical research, co-authoring 17 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Vibeke Horstmann
Is Vibeke Horstmann a top-rated expert for Delirium Tremens?
MediFind is an objective health platform that identifies experts based on real-world data. Vibeke Horstmann is classified as an Experienced expert for Delirium Tremens, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Vibeke Horstmann participate in research or clinical trials?
Yes. Vibeke Horstmann has published 17 articles and abstracts on conditions like Delirium Tremens. You can view a list of Vibeke Horstmann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Delirium TremensHorstmann isExperienced. Learn about Delirium Tremens.
- LymphedemaHorstmann isExperienced. Learn about Lymphedema.
- Milroy DiseaseHorstmann isExperienced. Learn about Milroy Disease.
- Neurotoxicity SyndromesHorstmann isExperienced. Learn about Neurotoxicity Syndromes.